KB001

BIOLOGICAL2 trials

Sponsors

Humanigen, Inc.

Conditions

Cystic FibrosisPseudomonas AeruginosaVentilator Associated Pneumonia

Phase 1

Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa

CompletedNCT00638365

Humanigen, Inc.Cystic Fibrosis

Start: 2008-03-31End: 2009-04-30Updated: 2014-06-09

Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa

CompletedNCT00691587

Humanigen, Inc.Pseudomonas Aeruginosa, Ventilator Associated Pneumonia

Start: 2008-04-30End: 2009-04-30Target: 36Updated: 2009-07-31

Related Papers

Anti-PcrV antibody in cystic fibrosis: A novel approach targeting <i>Pseudomonas aeruginosa</i> airway infection

Pediatric Pulmonology2013-09-09108 citations